Davis Capital Management
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1811806
JACKSONVILLE, FL
Position in ALNY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$602
+$272 QoQ
Shares Held
2
+100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#766
of 784 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Davis Capital Management holds $12,376 across 25 Biotechnology names. ALNY ranks #7 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8 | $3,973 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
4 | $749 | |
| 4 | RPRX |
Royalty Pharma plc
|
12 | $672 | |
| 5 | INSM |
INSMED Inc
|
6 | $639 | |
| 6 | MRNA |
Moderna, Inc.
|
9 | $630 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2 | $602 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
8 | $439 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602 | 2 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $330 | 1 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $397 | 1 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $456 | 1 | Shares | Sole | 2025-10-21 | |
| No filing history on record for this holder in this stock. | ||||||